[1]
|
Gosangi, B., Rubinowitz, A.N., Irugu, D., Gange, C., Bader, A. and Cortopassi, I. (2021) COVID-19 ARDS: A Review of Imaging Features and Overview of Mechanical Ventilation and Its Complications. Emergency Radiology.
https://doi.org/10.1007/s10140-021-01976-5
|
[2]
|
Welker, C., Huang, J., Gil, I.N. and Ramakrishna, H. (2021) Acute Respiratory Distress Syndrome Update, with Coronavirus Disease 2019 Focus. Journal of Cardiothoracic and Vascular Anesthesia, 1-8. (In Press)
https://doi.org/10.1053/j.jvca.2021.02.053
|
[3]
|
van De Veerdonk, F.L., Netea, M.G., van Deuren, M., van der Meer, J.W.M., De Mast, Q., et al. (2020) KKS Blockade in Patients with COVID-19 to Prevent Acute Respiratory Distress Syndrome (Apr 2020). ELife, 9, Article ID: E57555.
https://doi.org/10.7554/eLife.57555
|
[4]
|
Garvin, M.R., Alvarez, C., Miller, J.I., Prates, E.T. and Walker, A.M. (2020) A Mechanistic Model and Therapeutic Interventions for COVID-19 Involving a RAS Mediated Bradykinin Storm. ELife, 9, Article ID: E59177.
https://doi.org/10.7554/eLife.59177
|
[5]
|
Middleton, E.A. and Zimmerman, G.A. (2021) COVID-19-Associated Acute Respiratory Distress Syndrome: Lessons from Tissues and Cells. Critical Care Clinics, 37, 777-793. https://doi.org/10.1016/j.ccc.2021.05.004
|
[6]
|
Science Daily (2021, April 15) Two Distinct Types of COVID-19-Associated Acute Respiratory Distress Syndrome Identified.
https://www.sciencedaily.com/releases/2021/04/210415090727.htm
|
[7]
|
Volpe, M., Battistoni, A. and Mancia, G. (2016) Angiotensin II-Linked Hypothesis to Understand the Advantage of the Coevolution of Hypertension and Malaria. Circulation Research, 119, 1046-1048.
https://doi.org/10.1161/CIRCRESAHA.116.309855
|
[8]
|
Gallego-Delgado, J., Walther, T. and Rodriguez, A. (2016) The High Blood Pressure-Malaria Protection Hypothesis. Circulation Research, 119, 1071-1075.
https://doi.org/10.1161/CIRCRESAHA.116.309602
|
[9]
|
Biller, H., Zissel, G., Ruprecht, B., Nauck, M., Busse Grawitz, A. and Müller-Quernheim, J. (2006) Genotype-Corrected Reference Values for Serum Angiotensin-Converting Enzyme. European Respiratory Journal, 28, 1085-1091.
https://doi.org/10.1183/09031936.00050106
|
[10]
|
Rigat, B., Corvol, P. and Soubrier, F. (1990) An Insertion/deletion Polymorphism in the Angiotensin I-Converting Enzyme Gene Accounting for Half the Variance of Serum Enzyme Levels. Journal of Clinical Investigation, 86, 343-1346.
https://doi.org/10.1172/JCI114844
|
[11]
|
Radzikowska, U., Ding, M., Tan, G., Zhakparov, D., Peng, Y., Wawrzyniak, P., et al. (2020) Distribution of ACE2, CD147, CD26, and Other SARS-CoV-2 Associated Molecules in Tissues and Immune Cells in Health and in Asthma, COPD, Obesity, Hypertension, and COVID-19 Risk Factors. Allergy, 75, 2828-2845.
https://doi.org/10.1111/all.14429
|
[12]
|
Manne, B.K., Denorme, F., Middleton, E.A., Portier, I., Rowley, J.K., et al. (2020) Platelet Gene Expression and Function in Patients with COVID-19. Blood, 136, 1317-1329. https://doi.org/10.1182/blood.2020007214
|
[13]
|
McCracken, I.R., Saginc, G., He, L., Huseynov, A., Daniels, A., et al. (2021) Lack of Evidence of Angiotensin-Converting Enzyme 2 Expression and Replicative Infection by SARS-CoV-2 in Human Endothelial Cells. Circulation, 143, 865-868.
https://doi.org/10.1161/CIRCULATIONAHA.120.052824
|
[14]
|
Ganier, C., Du-Harpur, X., Harun, N., Wan, B., Arthurs, C., et al. (2020) CD147 (BSG) But Not ACE2 Expression Is Detectable in Vascular Endothelial Cells Within Single Cell RNA Sequencing Datasets Derived from Multiple Tissues in Healthy Individuals (bioRxiv Preprint). https://doi.org/10.1101/2020.05.29.123513
|
[15]
|
Zwaveling, S., van Wijk, R.G. and Karim, F. (2020) Pulmonary Edema in COVID-19: Explained by Bradykinin? Journal of Allergy and Clinical Immunology, 146, 1454-1455. https://doi.org/10.1016/j.jaci.2020.08.038
|
[16]
|
Takahashi, T., Yamaguchi, E., Furuya, K. and Kawakami, Y. (2001) The ACE Gene Polymorphism and Cough Threshold for Capsaicin after Cilazapril Usage. Respiratory Medicine, 95, 130-135. https://doi.org/10.1053/rmed.2000.1005
|
[17]
|
Bas, M., Hoffmann, T.K., Tiemann, B., Thao-Vi Dao, V., Bantis, C., et al. (2010) Potential Genetic Risk Factors in Angiotensin-Converting Enzymeinhibitor-Induced Angio-Edema. British Journal of Clinical Pharmacology, 69, 179-186.
https://doi.org/10.1111/j.1365-2125.2009.03567.x
|
[18]
|
Mukae, S., Itoh, S., Aoki, S., Iwata, T., Nishio, K., Sato, R., et al. (2002) Association of Polymorphisms of the Renin-Angiotensin System and Bradykinin B2 Receptor with ACE-Inhibitor-Related Cough. Journal of Human Hypertension, 16, 857-863.
https://doi.org/10.1038/sj.jhh.1001486
|
[19]
|
Vahey, G.M., Marshall, K.E., McDonald, E., Martin, S.W., Tate, J.E., et al. (2021). Symptom Profiles and Progression in Hospitalized and Nonhospitalized Patients with Coronavirus Disease, Colorado, USA, 2020. Emerging Infectious Diseases, 27, 385-395. https://doi.org/10.3201/eid2702.203729
|
[20]
|
Raveendran, A.V., Jayadevan, R. and Sashidharan, S. (2021) Long COVID: An Overview. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 15, 869-875. https://doi.org/10.1016/j.dsx.2021.04.007
|
[21]
|
Gallagher, P.E., Li, P., Lenhart, J.R., Chappell, M.C., Bridget, K., et al. (1999) Estrogen Regulation of Angiotensin-Converting Enzyme MRNA. Hypertension, 33, 323-328. https://doi.org/10.1161/01.HYP.33.1.323
|
[22]
|
Graham, E.L., Clark, J.R., Orban, Z.S., Lim, P.H., Szymanski, A.L., et al. (2021) Persistent Neurologic Symptoms and Cognitive Dysfunction in Nonhospitalized Covid19 “long Haulers”. Annals of Clinical and Translational Neurology, 8, 1073-1085.
https://doi.org/10.1002/acn3.51350
|
[23]
|
Becker, J.H., Lin, J.J., Doernberg, M., Stone, K., Navis, A., Festa, J.R., et al. (2021) Assessment of Cognitive Function in Patients after COVID-19 Infection. JAMA Network Open, 4, Article ID: E2130645.
https://doi.org/10.1001/jamanetworkopen.2021.30645
|
[24]
|
Brusco, I., Justino, A.B., Silva, C.S., Fischer, S., Cunha, T.M, et al. (2019) Kinins and Their B1 and B2 Receptors Are Involved in Fibromyalgia-Like Pain Symptoms in Mice. Biochemical Pharmacology, 168, 119-132.
https://doi.org/10.1016/j.bcp.2019.06.023
|
[25]
|
Joshi, S., Gomez, S., Duran-Mendez, M., Quiroz-Olvera, J., Garcia, C., et al. (2019) Aging Healthy, Or with Diabetes, Is Associated with ACE2/ACE Imbalance in the Hematopoietic Stem Progenitor Cells. The FASEB Journal, 33, 514.7-514.7.
https://doi.org/10.1096/fasebj.2019.33.1_supplement.514.7
|
[26]
|
Bank, S., Kumar De, S., Bankura, B., Maiti, S., Das, M., et al. (2021) ACE/ACE2 Balance Might Be Instrumental to Explain the Certain Comorbidities Leading to Severe COVID-19 Cases. Bioscience Reports, 41, Article ID: BSR20202014.
https://doi.org/10.1042/BSR20202014
|
[27]
|
Diorio, C., Henrickson, S.E., Vella, L.A., McNerney, K.O., Chase, J., et al. (2020) Multisystem Inflammatory Syndrome in Children and COVID-19 Are Distinct Presentations of SARS–CoV-2. Journal of Clinical Investigation, 130, 5967-5975.
https://doi.org/10.1172/JCI140970
|
[28]
|
Mirabito, K.M., Hilliard, L.M., Kett, M.M., Brown, R.D., Booth, S.C., et al. (2014) Sex- and Age-Related Differences in the Chronic Pressure Natriuresis Relationship: Role of the Angiotensin Type 2 Receptor. American Journal of Physiology—Renal Physiology, 307, F901-F907. https://doi.org/10.1152/ajprenal.00288.2014
|
[29]
|
Feng, W., Xu, X., Zhao, G., Zhao, J. and Dong, R. (2016) Increased Age-Related Cardiac Dysfunction in Bradykinin B2 Receptor Deficient Mice. The Journals of Gerontology: Series A, 71, 178-187. https://doi.org/10.1093/gerona/glu210
|
[30]
|
Abadir, P.M., Periasamy, A., Carey, R.M. and Siragy, H.M. (2006) Angiotensin II Type 2 Receptor-Bradykinin B2 Receptor Functional Heterodimerization. Hypertension, 48, 316-322. https://doi.org/10.1161/01.HYP.0000228997.88162.a8
|
[31]
|
Fernandes, F.B., Fernandes, A.B., Febba, A.C.S., Leite, A.P.O., Leite, C.A., Vitalle, M.S.S., et al. (2021) Association of Ang-(1-7) and Des-Arg9BK as New Biomarkers of Obesity and Cardiometabolic Risk Factors in Adolescents. Hypertension Research, 44, 969-977. https://doi.org/10.1038/s41440-021-00618-0
|
[32]
|
Yanes Cardozo, L.L. and Romero, D.G. (2021) Novel Biomarkers of Childhood and Adolescent Obesity. Hypertension Research, 44, 1030-1033.
https://doi.org/10.1038/s41440-021-00651-z
|
[33]
|
Rafferty, M.S., Burrows, H., Joseph, J.P., Leveille, J., Nihtianova, S. and Amirian, S. (2021) Multisystem Inflammatory Syndrome in Children (MIS-C) and the Coronavirus Pandemic: Current Knowledge and Implications for Public Health. Journal of Infection and Public Health, 14, 484-494. https://doi.org/10.1016/j.jiph.2021.01.008
|
[34]
|
Most, Z.M., Hendren, N., Drazner, M.H. and Perl, T.M. (2021) Striking Similarities of Multisystem Inflammatory Syndrome in Children and a Myocarditis-Like Syndrome in Adults. Circulation, 143, 4-6.
https://doi.org/10.1161/CIRCULATIONAHA.120.050166
|
[35]
|
Berger, A. (2000) T Lymphocytes Are a Major Source of Cytokines. BMJ, 321, 424.
https://doi.org/10.1136/bmj.321.7258.424
|
[36]
|
Maalmi, H., Berraïes, A., Tanguouru, E., Ammar, J., Abid, H., et al. (2012) The Impact of Vitamin D Deficiency on Immune T Cells in Asthmatic Children: A Case-Control Study. Journal of Asthma and Allergy, 5, 11-19.
https://doi.org/10.2147/JAA.S29566
|
[37]
|
Pavel, A., Glickman, J.W., Michels, J.R., Kim-Schultze, S., Miller, R.L., et al. (2021) Th2/Th1 Cytokine Imbalance Is Associated with Higher COVID-19 Risk Mortality. Frontiers in Genetics, 12, Article ID: 706902.
https://doi.org/10.3389/fgene.2021.706902
|
[38]
|
Sriskandan, S. and Cohen, J. (2000) Kallikrein-Kinin System Activation in Streptococcal Toxic Shock Syndrome. Clinical Infectious Diseases, 30, 961-962.
https://doi.org/10.1086/313827
|
[39]
|
Bengtson, S.H., Phagoo, S.B., Norrby-Teglund, A., Pahlman, L., Mörgelin, M., et al. (2006) Kinin Receptor Expression during Staphylococcus aureus Infection. Blood, 108, 2055-2063. https://doi.org/10.1182/blood-2006-04-016444
|
[40]
|
Patel, P., DeCuir, J., Abrams, J., Campbell, A.P., Godfred-Cato, S. and Belay, E.D. (2021) Clinical Characteristics of Multisystem Inflammatory Syndrome in Adults a Systematic Review. JAMA Network Open, 4, Article ID: E2126456.
https://doi.org/10.1001/jamanetworkopen.2021.26456
|
[41]
|
Fodil, S. and Annane, D. (2021) Complement Inhibition and COVID-19: the Story So Far. ImmunoTargets and Therapy, 10, 273-284.
https://doi.org/10.2147/ITT.S284830
|
[42]
|
Biezeveld, M.H., Kuipers, I.M., Geissler, J., Lam, J., Ottenkamp, J.J., et al. (2003) Association of Mannose-Binding Lectin Genotype with Cardiovascular Abnormalities in Kawasaki Disease. The Lancet, 361, 1268-1270.
https://doi.org/10.1016/S0140-6736(03)12985-6
|
[43]
|
Polycarpou, A., Grigoriadou, S., Klavinskis, L. and Sacks, S. (2021) Does the Lectin Complement Pathway Link Kawasaki Disease and SARSCoV-2? Frontiers in Immunology, 11, Article ID: 604512. https://doi.org/10.3389/fimmu.2020.604512
|
[44]
|
Qi, Y., Xu, J., Lin, Z., Tao, Y., Zheng, F., et al. (2021) The Network of Pro-Inflammatory Factors CD147, DcR3, and IL33 in the Development of Kawasaki Disease. Journal of Inflammation Research, 14, 6043-6053.
https://doi.org/10.2147/JIR.S338763
|
[45]
|
Chambers, P.W. (2020) COVID-19, ARDS, ACOVCS, MIS-C, KD, PMIS, TSS, MIS-A: Connecting the Alphabet? (See Figures 4,5). Clinical in Medicine, 2, Article No. 1027. http://doi.org/10.33597/2688-6731-V2-id1027
|
[46]
|
Kollias, G. and Sfikakis, P.P. (2010) TNF Pathophysiology. Molecular and Cellular Mechanisms. Current Directions in Autoimmunity, Vol. 11, Karger, Basel, 145-156.
https://doi.org/10.1159/isbn.978-3-8055-9384-7
|
[47]
|
Hu, J., Lei, L., Wang, Y., Wang, K., Hu, X., et al. (2016) Interleukin-6 Drives Multiple Myeloma Progression by Up-Regulating of CD147/Emmprin Expression. Blood, 128, 5632. https://doi.org/10.1182/blood.V128.22.5632.5632
|
[48]
|
Regal-McDonald, K. and Patel, R.P. (2020) Selective Recruitment of Monocyte Sub-Sets by Endothelial Nglycans. The American Journal of Pathology, 190, 947-957. https://doi.org/10.1016/j.ajpath.2020.01.006
|
[49]
|
Heller, M., von der Ohe, M., Kleene, R., Mohajer, H. and Schachner, M. (2003) The Immunoglobulin-Superfamily Molecule Basigin Is a Binding Protein for Oligomannosidic Carbohydrates: An Anti-Idiotypic Approach. Journal of Neurochemistry, 84, 557-565. https://doi.org/10.1046/j.1471-4159.2003.01537.x
|
[50]
|
Wang, K., Chen, W., Zhang, Z., Deng, Y., Lian, J.Q., Du, P., et al. (2020) CD147-Spike Protein Is a Novel Route for SARS-CoV-2 Infection to Host Cells. Signal Transduction and Targeted Therapy, 5, Article No. 283.
https://doi.org/10.1038/s41392-020-00426-x
|
[51]
|
Ragotte, R.J., Pulidoa, D., Donnellana, F.R., Hill, M.L., Gorini, G., Davies, H., et al. (2021) Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein. MSphere, 6, Article ID: E00647-21.
https://doi.org/10.1128/mSphere.00647-21
|
[52]
|
Shilts, J., Crozier, T.W.M., Greenwood, E.J.D., Lehner, P.J. and Wright, G.J. (2021) No Evidence for Basigin/CD147 as a Direct SARS-CoV-2 Spike Binding Receptor. Scientific Reports, 11, Article No. 413. https://doi.org/10.1038/s41598-020-80464-1
|
[53]
|
Chambers, P.W. (2021) Basigin Binds Spike S on SARS2. Open Access Library Journal, 8, Article No. E8064. https://doi.org/10.4236/oalib.1108064
|
[54]
|
Ahmetaj-Shala, B., Vaja, R., Atanur, S.S., George, P.M., Kirkby, N.S., et al. (2020) Cardiorenal Tissues Express SARS-CoV-2 Entry Genes and Basigin (BSG/CD147) Increases with Age in Endothelial Cells. JACC: Basic to Translational Science, 5, 1111-1123. https://doi.org/10.1016/j.jacbts.2020.09.010
|
[55]
|
Sarangarajan, R., Winn, R., Kiebish, M.A., Bountra, C., Granger, E. and Narain, N.R. (2021) Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers. Journal of Racial and Ethnic Health Disparities, 8, 973-980. https://doi.org/10.1007/s40615-020-00853-0
|
[56]
|
Al-Hinai, A.T., Hassan, M.O., Simsek, M., Al-Barwani, H. and Bayoumi, R. (2002) Genotypes and Allele Frequencies of Angiotensin Converting Enzyme (ACE) Insertion/deletion Polymorphism among Omanis, Table 2. SQU Journal for Scientific Research: Medical Sciences, 4, 25-27.
https://applications.emro.who.int/imemrf/SQUMJ_2002_4_1_2_25.pdf
|
[57]
|
Kranes, S., Gove, T., Dodson, K., Jacobson, A., Latourelle, S. and Elwess, N. (2021) The Polymorphic ACE Gene and Resulting Genotypes and Allele Frequencies Within Specific Groups. SUNY Plattsburgh’s Scientia Discipulorum Journal of Undergraduate Research, 8, 1-7. http://hdl.handle.net/20.500.12648/1281
|
[58]
|
Min, S.K.K., Takahashi, K., Ishigami, H., Hiranuma, K., Mizuno, M., Ishii, T., et al. (2009) Is There a Gender Difference between ACE Gene and Race Distance? Applied Physiology, Nutrition, and Metabolism, 34, 926-932.
https://doi.org/10.1139/H09-097
|
[59]
|
Regatieria, I.C., Almeida, M.L.M., Neto, A.R.T., Curi, R.A., Ferraz, G.C. and Queiroz-Neto, A. (2016) Quantification of MCT1 and CD147 in Red Blood Cells of Arabian and Quarter Horses. Journal of Equine Veterinary Science, 43, 66-71.
https://doi.org/10.1016/j.jevs.2016.05.004
|
[60]
|
Avolio, E., Carrabba, M., Milligan, R., Williamson, M.K. and Beltrami, A.P. (2021) The SARS-CoV-2 Spike Protein Disrupts Human Cardiac Pericytes Function Through CD147-Receptor-Mediated Signaling: A Potential Noninfective Mechanism of COVID-19 Microvascular Disease. Clinical Science, 135, 2667-2689.
https://doi.org/10.1042/CS20210735
|
[61]
|
Debreczeni, M.L., Németh, Z., Kajdácsi, E., Schwaner, E., Makó, V., et al. (2019) MASP-1 Increases Endothelial Permeability. Frontiers in Immunology, 10, Article No. 991. https://doi.org/10.3389/fimmu.2019.00991
|
[62]
|
Kang, D. and Kim, S. (2019) Clinical Aspects of Splenomegaly as a Possible Predictive Factor of Coronary Artery Changes in Kawasaki Disease. Cardiology in the Young, 29, 297-302. https://doi.org/10.1017/S1047951118002238
|
[63]
|
Urra, J.M., Cabrera, C.M., Porras, L. and Rodenas, I. (2020) Selective CD8 Cell Reduction by SARS-CoV-2 Is Associated with a Worse Prognosis and Systemic Inflammation in COVID-19 Patients. Clinical Immunology, 217, Article ID: 08486.
https://doi.org/10.1016/j.clim.2020.108486
|
[64]
|
Zhang, K., Li, Z., Li, M., Zhang, Y., Wu, S. and Chen, C. (2017) Increase in T Helper Type 17 Cells in Children with Kawasaki Disease Is NR4A2 Dependent. European Journal of Inflammation, 16, 1-8. https://doi.org/10.1177/2058739218760945
|
[65]
|
Mavragani, C.P., Spyridakis, E.G. and Koutsilieris, M. (2012) Adult-Onset Still’s Disease: from Pathophysiology to Targeted Therapies. International Journal of Inflammation, 2012, Article ID: 879020, 10 p. https://doi.org/10.1155/2012/879020
|
[66]
|
Uyguna, T., Demir, B., Tosuna, V., Ungan, I., Kural, A., et al. (2019) Relationship between Interleukin-17A and Isolated Coronary Ectasia. Cytokine, 115, 84-88.
https://doi.org/10.1016/j.cyto.2018.11.015
|
[67]
|
Cogan, E., Foulon, P, Cappeliez, O., Dolle, N., Vanfraechem, G. and De Backer, D. (2020) Multisystem Inflammatory Syndrome with Complete Kawasaki Disease Features Associated with SARS-CoV-2 Infection in a Young Adult. A Case Report. Frontiers in Medicine, 7, Article No. 428. https://doi.org/10.3389/fmed.2020.00428
|
[68]
|
Axis, M., Fatima, R. and Assaly, R. (2020) An Inflammatory Cytokine Signature Predicts COVID-19 Severity and Survival. Journal of Medical Virology, 92, 2283-2285.
https://doi.org/10.1002/jmv.25948
|
[69]
|
Aliza, M. (2020) Elevated Interleukin-6 and Severe COVID-19: A Meta-Analysis. Journal of Medical Virology, 92, 2283-2285. https://doi.org/10.1002/jmv.25948
|
[70]
|
Grant, O.C., Montgomery, D., Ito, K. and Woods, R.J. (2020) Analysis of the SARS-CoV-2 Spike Protein Glycan Shield Reveals Implications for Immune Recognition. Scientific Reports, 10, Article No. 14991.
https://doi.org/10.1038/s41598-020-71748-7
|
[71]
|
Bullen, G., Galson, J.D., Hall, G., Villar, P. and Moreels, L. (2021) Cross-Reactive SARS-CoV-2 Neutralizing Antibodies from Deep Mining of Early Patient Responses. Frontiers in Immunology, 15, Article No. 678570.
https://doi.org/10.3389/fimmu.2021.678570
|
[72]
|
Geng, J., Chen, L., Yuan, Y., Wang, K., Wang, Y., Qin, C., et al. (2021) CD147 Antibody Specifically and Effectively Inhibits Infection and Cytokine Storm of SARS-CoV-2 and Its Variants Delta, Alpha, Beta, and Gamma. Signal Transduction and Targeted Therapy, 6, Article No. 347.
https://doi.org/10.1038/s41392-021-00760-8
|
[73]
|
Federica Defendi, F., Leroy, C., Epaulard, O., Clavarino, G., Vilotitch, A., et al. (2021) Complement Alternative and Mannose-Binding Lectin Pathway Activation Is Associated with COVID-19 Mortality. Frontiers in Immunology, 10, Article No. 742446. https://doi.org/10.3389/fimmu.2021.742446
|
[74]
|
Bian, H., Zheng, Z.H., Wei, D., Wen, A., Zhang, Z., Lian, J.Q., et al. (2021) Safety and Efficacy of Meplazumab in Healthy Volunteers and COVID-19 Patients: A Randomized Phase 1 and an Exploratory Phase 2 Trial. Signal Transduction and Targeted Therapy, 6, Article No. 194. https://doi.org/10.1038/s41392-021-00603-6
|
[75]
|
Rambaldi, A., Gritti, G., Micò, M.C., Frigeni, M., Borleri, G., et al. (2020) Endothelial Injury and Thrombotic Microangiopathy in COVID-19: Treatment with the Lectin-Pathway Inhibitor Narsoplimab. Immunobiology, 225, Article ID: 152001.
https://doi.org/10.1016/j.imbio.2020.152001
|
[76]
|
Knierman, M.D., Gelfanova, V., Zlatniski, N.A., Mullen, J.H., Siegel, R.W. and Konrad, R.J. (2021) Severe SARS-CoV-2 Infection Treated with the Mannose Binding Lectin Associated Serine Protease 2 (MASP2) Inhibitor Narsoplimab. Journal of Allergy and Infectious Diseases, 2, 24-28.
|
[77]
|
Bumiller-Bini, V., De Freitas Oliveira-Toré, C., Carvalho, T.M., Kretzschmar, G.C., Gonçalves, L.B., et al. (2021) MASPs at the Crossroad between the Complement and the Coagulation Cascades—The Case for COVID-19 (2021). Genetics and Molecular Biology, 44, Article ID: e20200199.
https://doi.org/10.1590/1678-4685-gmb-2020-0199
|
[78]
|
Gralinskia, L.E., Sheahana, T.P., Morrison, T.E., Menacherya, V.D., Jensen, K., et al. (2018) Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis. Host-Microbe Biology, 9, Article No. e01753-18.
https://doi.org/10.1128/mBio.01753-18
|
[79]
|
Biryukov, S. and Stoute, J.A. (2014) Complement Activation in Malaria: Friend or Foe? Trends in Molecular Medicine, 20, 293-301.
https://doi.org/10.1016/j.molmed.2014.01.001
|
[80]
|
Elhadad, S., Chapin, J., Copertino, D., van Besien, K., Ahamed, J. and Laurence, J. (2021) MASP2 Levels Are Elevated in Thrombotic Microangiopathies: Association with Microvascular Endothelial Cell Injury and Suppression by Anti-MASP2 Antibody Narsoplimab. Clinical and Experimental Immunology, 203, 96-104.
https://doi.org/10.1111/cei.13497
|
[81]
|
Magro, C., Mulvey, J.J., Berlin, D., Harp, J., Baxter-Stoltzfus, A., Laurence, J., et al. (2020) Complement Associated Microvascular Injury and Thrombosis in the Pathogenesis of Severe COVID-19 Infection: A Report of Five Cases. The Journal of Laboratory and Clinical Medicine, 220, 1-13.
https://doi.org/10.1016/j.trsl.2020.04.007
|
[82]
|
Eriksson, O., Hultström, M., Persson, B., Lipcsey, M., Ekdahl, K.N., et al. (2020) Mannose-Binding Lectin Is Associated with Thrombosis and Coagulopathy in Critically Ill COVID-19 Patients. Thrombosis and Haemostasis, 120, 1720-1724.
https://doi.org/10.1055/s-0040-1715835
|
[83]
|
US Government Clinical Trials (2020). (CBDRA60) to Prevent Or Reduce Symptoms of COVID-19 and Prevention of Post-Acute Sequelae of SARS-CoV-2 Infection PASC. https://www.clinicaltrials.gov/ct2/show/NCT04777981
|
[84]
|
Barre, A., van Damme, E.J.M., Simplicien, M., Le Poder, S., Klonjkowski, B., et al. (2021) Mannose-Specific Lectins from Plants, Fungi, Algae and Cyanobacteria, as Potential Blockers for SARS-CoV, MERS-CoV and SARSCoV-2 (COVID-19) Coronaviruses: Biomedical Perspectives. Cells, 10, Article No. 1619.
https://doi.org/10.3390/cells10071619
|
[85]
|
Ogata, A.F., Cheng, C., Desjardins, M., Senussi, Y., Sherman, A.C., et al. (2021) Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of MRNA-1273 Vaccine Recipients. Clinical Infectious Diseases, Article No. ciab465. https://doi.org/10.1093/cid/ciab465
|
[86]
|
Japanese Government (n.d.) SARS-CoV-2 MRNA Vaccine (BNT162, PF-07302048). In: Pfizer Report, Japanese Government, Tokyo, 6.
https://www.docdroid.net/xq0Z8B0/pfizer-Reportjapanesegovernmentpdf#page=16
|
[87]
|
Out of Mind (2021, August 22).
https://www.oom2.com/t76590-Shocking-New-Study-Reveals-Covid-Vaccines-Do-Permanent-Damage-To-62-Of-Recipients
|
[88]
|
Gupta, A., Sardar, P., Cash, M.E., Milani, R.V. and Lavie, C.J. (2021) Covid-19 Vaccine-Induced Thrombosis and Thrombocytopenia—A Commentary on an Important and Practical Clinical Dilemma. Progress in Cardiovascular Diseases, 67, 105-107.
https://doi.org/10.1016/j.pcad.2021.05.001
|
[89]
|
Arepally, G.M. (2017) Heparin-Induced Thrombocytopenia. Blood, 129, 2864-2872.
https://doi.org/10.1182/blood-2016-11-709873
|
[90]
|
Warkentin, T.E. and Dager, W.E. (2005) Chapter 24. Heparin-Induced Thrombocytopenia. In: Garg, H.G., Linhardt, R.J. and Hales, C.A., Eds., Chemistry and Biology of Heparin and Heparan Sulfate, Elsevier Science, Amsterdam, 673-697.
https://doi.org/10.1016/B978-008044859-6/50025-3
|
[91]
|
Clausen, T.M., Sandoval, D.R., Spliid, C.B., Ward, A.B., Carlin, A.F., et al. (2020) SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2. Cell, 183, 1043-1057.E15. https://doi.org/10.1016/j.cell.2020.09.033
|
[92]
|
Scully, M., Singh, D., Lown, R., Poles, A.K., Solomon, T., et al. (2021) Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 NCoV-19 Vaccination. New England Journal of Medicine, 384, 2202-2211. https://doi.org/10.1056/NEJMoa2105385
|
[93]
|
Comer, S.P., Cullivan, S., Szklanna, P.B., Weiss, L., Cullen, S., et al. (2021) COVID-19 Induces a Hyperactive Phenotype in Circulating Platelets. PLoS Biology, 19, Article ID: E3001109. https://doi.org/10.1371/journal.pbio.3001109
|
[94]
|
Saburova, O.A., Butina, T.Yu., Ryumin, A.M., Mikhailova, E.A. and Sobchak, D.M. (2020) Immunological Criteria for Predicting Severe and Complicated Forms of Chickenpox. Sovremennye Tehnologii V Medicine, 12, 48-54.
https://doi.org/10.17691/stm2020.12.4.06
|
[95]
|
Elsaie, M.L., Youssef, E.A. and Nada, H.A. (2020) Herpes Zoster Might Be an Indicator for Latent COVID 19 Infection. Dermatologic Therapy, 33, Article ID: e13666.
https://doi.org/10.1111/dth.13666
|
[96]
|
van Dam, C.S., Lede, I., Schaar, J., Al-Dulaimy, M., Rösken, R. and Smits, M. (2021) Herpes Zoster after COVID Vaccination. International Journal of Infectious Diseases, 111, 169-171. https://doi.org/10.1016/j.ijid.2021.08.048
|
[97]
|
Channa, L., Torre, K. and Rothe, M. (2021) Herpes Zoster Reactivation after MRNA-1273 (Moderna) SARS-CoV-2 Vaccination. American Academy of Dermatology, 15, 60-61. https://doi.org/10.1016/j.jdcr.2021.05.042
|
[98]
|
Shah, S., Baral, B., Chamlagain, R., Murarka, H., Adhikari, Y.R., et al. (2021) Reactivation of Herpes Zoster after Vaccination with an Inactivated Vaccine: A Case Report from Nepal. Clinical Case Reports, 9, Article ID: e05188.
https://doi.org/10.1002/ccr3.5188
|
[99]
|
Steain, M., Sutherland, J.P., Rodriguez, M., Cunningham, A.L., Barry Slobedman, B., et al. (2014) Analysis of T Cell Responses during Active Varicella-Zoster Virus Reactivation in Human Ganglia. Journal of Virology, 88, 2704-2716.
|
[100]
|
Serrano-Villar, S., Sainz, T., Lee, S.A., Hunt, P.W., Sinclair, E., Barbara, L., et al. (2014) HIV-Infected Individuals with Low CD4/CD8 Ratio Despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+ T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality. PLoS Pathogens, 10, Article ID: e1004078. https://doi.org/10.1371/journal.ppat.1004078
|
[101]
|
Ostroumov, D., Fekete-Drimusz, N., Saborowski, M., Kühnel, F. and Woller, N. (2018) CD4 and CD8 T Lymphocyte Interplay in Controlling Tumor Growth. Cellular and Molecular Life Sciences, 75, 689-713.
https://doi.org/10.1007/s00018-017-2686-7
|
[102]
|
Knutti, N., Huber, O. and Friedrich, K. (2019) CD147 (EMMPRIN) Controls Malignant Properties of Breast Cancer Cells by Interdependent Signaling of WNT and JAK/STAT Pathways. Molecular and Cellular Biochemistry, 451, 197-209.
https://doi.org/10.1007/s11010-018-3406-9
|
[103]
|
Chen, Y., Xu, J., Wu, X., Yao, H., Yan, Z., Guo, T., et al. (2020) CD147 Regulates Antitumor CD8+ T-Cell Responses to Facilitate Tumor-Immune Escape. Cellular & Molecular Immunology, 18, 1995-2009. https://doi.org/10.1038/s41423-020-00570-y
|
[104]
|
Zheng, H. and Gong, B. (2017) CD147 Expression Was Positively Linked to Aggressiveness and Worse Prognosis of Gastric Cancer: A Meta and Bioinformatics Analysis. Oncotarget, 8, 90358-90370. https://doi.org/10.18632/oncotarget.20089
|
[105]
|
Nabeshima, K., Iwasaki, H., Koga, K., Hojo, H., Suzumiya, J., et al. (2006) Emmprin (Basigin/CD147): Matrix Metalloproteinase Modulator and Multifunctional Cell Recognition Molecule That Plays a Critical Role in Cancer Progression. Pathology International, 56, 359-367. https://doi.org/10.1111/j.1440-1827.2006.01972.x
|
[106]
|
Global Research (2021, September) Diagnostic Lab Certified Pathologist Reports 20 Times Increase of Cancer in Vaccinated Patients.
https://www.globalresearch.ca/owner-Diagnostic-Labreports-20-Timesincrease-Cancer-Vaccinated-Patients/5756399
|
[107]
|
Henderson, L.A., Hoyt, K.J., Lee, P.Y., Rao, D.A., Jonsson, A.H., et al. (2020) Th17 Reprogramming of T Cells in Systemic Juvenile Idiopathic Arthritis. JCI Insight, 5, Article ID: e132508. https://doi.org/10.1172/jci.insight.132508
|
[108]
|
De Zuani, M., Laznicková, P., Tomasková, V., Dvoncová, M., Forte, G., et al. (2021) High CD4-To-CD8 Ratio Identifies an At-Risk Population Susceptible to Lethal COVID-19. Scandinavian Journal of Immunology, Early View, Article ID: e13125.
https://doi.org/10.1111/sji.13125
|
[109]
|
Ngono, A.E., Syed, T., Nguyen, X.V., Regla-Navamercylia, J.A., Tono, S., et al. (2020) CD8+ T Cells Mediate Protection Against Zika Virus Induced by an NS3-Based Vaccine. Science Advances, 6, Article ID: eabb2154.
https://doi.org/10.1126/sciadv.abb2154
|
[110]
|
Kulkarni R. (2020) Antibody-Dependent Enhancement of Viral Infections. In: Bramhachari, P., Ed., Dynamics of Immune Activation in Viral Diseases, Springer, Singapore, 9-41. https://doi.org/10.1007/978-981-15-1045-8_2
|
[111]
|
Zellweger, R.M., Eddy, W.E., Tang, W.W., Miller, R. and Shresta, S. (2014) CD8+ T Cells Prevent Antigen-Induced Antibody-Dependent Enhancement of Dengue Disease in Mice. The Journal of Immunology, 193, 4117-4124.
https://doi.org/10.4049/jimmunol.1401597
|
[112]
|
Yahi, N., Chahinian, H. and Fantini, J. (2021) Infection-Enhancing Anti-SARS-CoV-2 Antibodies Recognize Both the Original Wuhan/D614G Strain and Delta Variants. A Potential Risk for Mass Vaccination? Journal of Infection, 83, 607-635. https://doi.org/10.1016/j.jinf.2021.08.010
|
[113]
|
Tanioka, H., Tanioka, S. and Kaga, K. (2021) Ivermectin for River Blindness and Malaria Why COVID-19 Is Not So Spread in Africa: How Does Ivermectin Affect It? MedRxiv 2021.03.26.21254377. https://doi.org/10.1101/2021.03.26.21254377
|
[114]
|
Scheim, D. (2020) Ivermectin for COVID-19 Treatment: Clinical Response at Quasi-Threshold Doses via Hypothesized Alleviation of CD147-Mediated Vascular Occlusion. https://doi.org/10.2139/ssrn.3636557
|
[115]
|
Haslam, S.M., Houston, K.M., Harnett, W., Reason, A.J. and Morris, H.R. (1999) Structural Studies of N-Glycans of Filarial Parasites. Conservation of Phosphorylcholine-Substituted Glycans among Species and Discovery of Novel Chito-Oligomers. Journal of Biological Chemistry, 274, 20953-20960.
https://doi.org/10.1074/jbc.274.30.20953
|
[116]
|
Coste, I., Gauchat, J.F., Wilson, A., Izui, S., Jeannin, P., et al. (2001) Unavailability of CD147 Leads to Selective Erythrocyte Trapping in the Spleen. Blood, 97, 3984-3988. https://doi.org/10.1182/blood.V97.12.3984
|
[117]
|
Balaban, D.V., Popp, A., Lungu, A.M., Costache, R.S., Anca, I.A., et al. (2025) Ratio of Spleen Diameter to Red Blood Cell Distribution Width. Medicine, 94, Article No. e726. https://doi.org/10.1097/MD.0000000000000726
|
[118]
|
Pouladzadeh, M., Safdarian, M., Choghakabodi, P.M., Amini, F. and Sokooti, A. (2021) Validation of Red Cell Distribution Width as a COVID-19 Severity Screening Tool. Future Science OA, 7, 7. https://doi.org/10.2144/fsoa-2020-0199
|
[119]
|
Foy, B.H., Phil, D., Carlson, J.C.T., Reinertsen, E., et al. (2020) Association of Red Blood Cell Distribution Width with Mortality Risk in Hospitalized Adults with SARSCoV-2 Infection. JAMA Network Open, 3, Article ID: e2022058.
https://doi.org/10.1001/jamanetworkopen.2020.22058
|
[120]
|
Srivastava, K., Cockburn, I.A., Swaim, A.M., Sullivan, D., Zavala, F., et al. (2008) Platelet Factor 4 Mediates Inflammation in Cerebral Malaria. Cell Host and Microbe, 4, 179-187. https://doi.org/10.1016/j.chom.2008.07.003
|
[121]
|
Campbell, R.A., Boilard, E. and Rondina, M.T. (2020) Is There a Role for the ACE2 Receptor in SARS-CoV-2 Interactions with Platelets? Journal of Thrombosis and Haemostasis, 19, 46-50. https://doi.org/10.1111/jth.15156
|
[122]
|
Yu, H.H., Qin, C., Chen, M., Wang, W. and Tian, D.S. (2020) D-Dimer Level Is Associated with the Severity of COVID-19. Thrombosis Research, 195, 219-225.
https://doi.org/10.1016/j.thromres.2020.07.047
|
[123]
|
Zong, X., Gu, Y., Yu, H., Li, Z. and Wang, Y. (2021) Thrombocytopenia Is Associated with COVID-19 Severity and Outcome: An Updated Meta-Analysis of 5637 Patients with Multiple Outcomes. Laboratory Medicine, 52, 10-15.
https://doi.org/10.1093/labmed/lmaa067
|
[124]
|
Tan, L., Wang, Q., Zhang, D., Ding, J., Huang, Q., Tang, Y.Q., et al. (2020) Lymphopenia Predicts Disease Severity of COVID-19: A Descriptive and Predictive Study. Signal Transduction and Targeted Therapy, 5, Article No. 33.
https://doi.org/10.1038/s41392-020-0148-4
|
[125]
|
Huang, I. and Pranata, R. (2020) Lymphopenia in Severe Coronavirus Disease-2019 (COVID-19): Systematic Review and Meta-Analysis. Journal of Intensive Care, 8, Article No. 36. https://doi.org/10.1186/s40560-020-00453-4
|
[126]
|
Meltzer, E., Keller, S., Shmuel, S. and Schwartza, E. (2019) D-Dimer Levels in Non-Immune Travelers with Malaria. Travel Medicine and Infectious Disease, 27, 104-106. https://doi.org/10.1016/j.tmaid.2018.05.004
|
[127]
|
Kalungi, A., Kinyanda, E., Akena, D.H., Kaleebu, P. and Bisangwa, I.M. (2021) Less Severe Cases of COVID-19 in Sub-Saharan Africa: Could Coinfection or a Recent History of Plasmodium Falciparum Infection Be Protective? Frontiers in Immunology, 18, Article ID: 565625. https://doi.org/10.3389/fimmu.2021.565625
|
[128]
|
Kusi, K.A., Frimpong, A., Partey, F.D., Lamptey, H., Amoah, L.E. and Ofori, M.F. (2021) High Infectious Disease Burden as a Basis for the Observed High Frequency of Asymptomatic SARS-CoV-2 Infections in Sub-Saharan Africa. AAS Open Research, 4, 2. https://doi.org/10.12688/aasopenres.13196.2
|
[129]
|
Crump, A. and Omura, S. (2011) Ivermectin, ‘Wonder Drug’ from Japan: The Human Use Perspective. Proceedings of the Japan Academy, Series B, 87, 13-28.
https://doi.org/10.2183/pjab.87.13
|
[130]
|
Pöltl, G., Kerner, D., Paschinger, K. and Wilson, I.B.H. (2007) N-Glycans of the Porcine Nematode Parasite Ascaris suum Are Modified with Phosphorylcholine and Core Fucose Residues. The FEBS Journal, 274, 714-726.
https://doi.org/10.1111/j.1742-4658.2006.05615.x
|
[131]
|
Mogire, R.M., Mutua, A., Kimita, W., Kamau, A., Bejon, P., et al. (2020) Prevalence of Vitamin D Deficiency in Africa: A Systematic Review and Meta-Analysis. Lancet, 8, E134-E142. https://doi.org/10.1016/S2214-109X(19)30457-7
|
[132]
|
Lima-Costa, M.F., Mambrini, J.V.M., De Souza-Junior, P.R.B., Bof de Andrade, F., Peixoto, S.V., Vidigal, C.M., et al. (2020) Nationwide Vitamin D Status in Older Brazilian Adults and Its Determinants: The Brazilian Longitudinal Study of Aging (ELSI). Scientific Reports, 10, Article No. 13521.
https://doi.org/10.1038/s41598-020-70329-y
|
[133]
|
Aparna, P., Muthathal, S., Nongkynrih, B. and Gupta, S.K. (2018) Vitamin D Deficiency in India. Journal of Family Medicine and Primary Care, 7, 324-330.
|
[134]
|
Scott, D.W., Chen, J., Chacko, B.K., Traylor Jr., J.G., Orr, A.W. and Patel. R.P. (2012) Role of Endothelial N-Glycan Mannose Residues in Monocyte Recruitment during Atherogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology, 32, e51-e59.
https://doi.org/10.1161/ATVBAHA.112.253203
|
[135]
|
Wang, C., Jin, R., Zhu, X., Yan, J. and Li, G. (2015) Function of CD147 in Atherosclerosis and Atherothrombosis. Journal of Cardiovascular Translational Research, 8, 59-66. https://doi.org/10.1007/s12265-015-9608-6
|
[136]
|
Bilezikian, J.P., Bikle, D., Hewison, M., Lazaretti-Castro, M., Formenti, A.M, et al. (2020) Vitamin D and COVID-19. European Journal of Endocrinology, 183, R133-R147. https://doi.org/10.1530/EJE-20-0665
|
[137]
|
Chambers, E.S., Vukmanovic-Stejic, M., Turner, C.T., Shih, B.B., Trahair, H., et al. (2021) Vitamin D3 Replacement Enhances Antigen-Specific Immunity in Older Adults. Immunotherapy Advances, 1, Article No. ltaa008.
https://doi.org/10.1093/immadv/ltaa008
|
[138]
|
Mercola, J., Grant, W.B. and Wagner, C.L. (2020) Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity. Nutrients, 12, Article No. 3361.
https://doi.org/10.3390/nu12113361
|
[139]
|
Campi, I., Gennari, L., Merlotti, D., Mingiano, C., Frosali, A., Giovanelli, L., et al. (2021) Vitamin D and COVID-19 Severity and Related Mortality: A Prospective Study in Italy. BMC Infectious Diseases, 21, Article No. 566.
https://doi.org/10.1186/s12879-021-06281-7
|
[140]
|
CDC (Centers for Disease Control and Prevention) (n.d.) Influenza (Flu).
https://www.cdc.gov/flu/about/burden/index.html
|
[141]
|
Martineau, A.R., Jolliffe, D.A., Hooper, R.L., Greenberg, L., Aloia, J.F., Bergman, P., et al. (2017) Vitamin D Supplementation to Prevent Acute Respiratory Tract Infections: Systematic Review and Meta-Analysis of Individual Participant Data. BMJ, 356, Article No. i6583. https://doi.org/10.1136/bmj.i6583
|
[142]
|
Vázquez-Lorente, H., Herrera-Quintana, L., Molina-López, J., Gamarra-Morales, Y., López-González, B., et al. (2020) Response of Vitamin D after Magnesium Intervention in a Postmenopausal Population from the Province of Granada, Spain. Nutrients, 12, Article No. 2283. https://doi.org/10.3390/nu12082283
|
[143]
|
Frieri, M. and Ashok, V. (2011) Vitamin D Deficiency as a Risk Factor for Allergic Disorders and Immune Mechanisms. Allergy and Asthma Proceedings, 32, 438-444.
https://doi.org/10.2500/aap.2011.32.3485
|
[144]
|
Ma, J.G., Wu, G.J., Xiao, H.L., Xiao, Y.M. and Zha, L. (2021) Vitamin D Has an Effect on Airway Inflammation and Th17/Treg Balance in Asthmatic Mice. Kaohsiung Journal of Medical Sciences, 37, 1113-1121. https://doi.org/10.1002/kjm2.12441
|
[145]
|
Pender, M.P. (2012) CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis. Autoimmune Diseases, 2012, Article ID: 189096. https://doi.org/10.1155/2012/189096
|